Results 221 to 230 of about 34,707 (260)

Shoulder arthroplasty in the osteoporotic patient: do bisphosphonates make a difference? [PDF]

JSES Int
Adams NC, Bank N, Kotseos CQ, Davis JR, Felkner JR, Creighton RA, Kamath GM.   +6 more
europepmc   +1 more source

Vascular Calcification: Mechanisms, Models, and Therapies

iNew Medicine, Volume 2, Issue 2, June 2026.
ABSTRACT Vascular calcification represents an active multifactorial process that mirrors several key features of skeletal bone mineralization. Clinically, it is characterized by diminished arterial compliance and increased arterial wall stiffness, both of which serve as independent predictors of significant adverse cardiovascular events.
Wenya Zhu, Shu Yang, Ziyi Chen, Xiaoxiao Yang, Zhen Liang, Yuanli Chen   +5 more
wiley   +1 more source

Risk factors for skeletal-related events in patients with stage IV lung adenocarcinoma and bone metastases receiving denosumab: a retrospective cohort analysis. [PDF]

Support Care Cancer
Zhang H, Wen D, Liao Z, Tan X, Wang H, Xiang J, Yan B.   +6 more
europepmc   +1 more source

Resorption Pattern and Bone Regeneration Using a Synthetic Bone Substitute Block With or Without rhBMP‐2 and Bisphosphonates: An in Vivo Experiment

Journal of Biomedical Materials Research Part B: Applied Biomaterials, Volume 114, Issue 6, June 2026.
ABSTRACT This study aimed to investigate whether recombinant human bone morphogenetic protein‐2 (rhBMP‐2) or bisphosphonate added to synthetic block bone substitute influences new bone formation and grafting material degradation patterns. In a rabbit calvarial model, four critical‐size bone defects were created and treated with a saline‐soaked ...
Seung Ha Yoo, Young Woo Song, Seung‐Hyun Park, Jae‐Hong Lim, Ronald Jung, Daniel Thoma, Ui‐Won Jung   +6 more
wiley   +1 more source

Comprehensive Dental Rehabilitation in a 6-Year-Old Child with Juvenile Focal Osteoporosis Receiving IV Bisphosphonate Therapy: A Case Report.

J Pharm Bioallied Sci
Alolayan RA.
europepmc   +1 more source

Prevalence of Low Bone Mineral Density Increases With Age in Sickle Cell Disease

eJHaem, Volume 7, Issue 3, June 2026.
ABSTRACT Introduction Skeletal complications are common in sickle cell disease (SCD). We previously showed that the prevalence of low areal bone mineral density (aBMD) increased with age in a pediatric SCD cohort, even after adjusting for short stature. Data on age‐related aBMD trends in young adults is lacking.
Jahnavi Gollamudi, Chengzhou Wu, Guolian Kang, Michael Sexton Lamonica, Pei‐Lin Chen, Ragha Srinivasan, Khalid El‐Bashir, Jane Hankins, Parul Rai, Clifford Takemoto, Hyacinth I. Hyacinth, Matthew R. Allen, Babette S. Zemel, Oyebimpe Adesina   +13 more
wiley   +1 more source

Long-term survival and phenotypic expansion in siblings with generalized arterial calcification of infancy. [PDF]

JCEM Case Rep
Resnick O, Ashraf A.
europepmc   +1 more source

Prevalence and Predisposing Factors of Helicobacter pylori Infection in Symptomatic Patients: A Multicenter Study in Ghana's Upper East Region

Public Health Challenges, Volume 5, Issue 2, June 2026.
A high Helicobacter pylori prevalence of 65.8% was detected among dyspeptic patients in northern Ghana, linked to poor sanitation, use of public toilets, consumption of street‐vended food, and drinking untreated water. These findings underscore the need for targeted public‐health interventions. ABSTRACT Background Helicobacter pylori (H.
Elvis Ramsy Awuni, Maxwell Akonde, Benedict Boateng Antuamwine   +2 more
wiley   +1 more source

Atypical Femur Fractures Without Bisphosphonate Exposure (AFFwB): A Retrospective Report of 21 Cases. [PDF]

J Clin Med
Lucchetta L, Ruggiero C, Berardi S, Franceschi A, Bisaccia M, Rinonapoli G.   +5 more
europepmc   +1 more source

Clinical and Genetic Characterization of Osteogenesis Imperfecta in Japanese Patients: Outcomes of Sequential Bisphosphonate Therapy. [PDF]

Calcif Tissue Int
Yamada C, Kubota T, Nakayama H, Ohata Y, Okamura S, Yamamoto K, Fujiwara M, Ozono K, Kitabatake Y.   +8 more
europepmc   +1 more source